JNJ Stock Price Prediction 2024 To 2030 – One of the biggest and most diverse healthcare companies in the world is Johnson & Johnson (J&J). The company’s activities can be divided into three business segments: pharmaceuticals, which account for 47% of revenues and 58% of operating profits; medical devices and diagnostics, which provide 36% of revenues and 31% of operating profits; and consumers, which provide 17% of revenues and 9% of operating profits.
About the Company – Johnson & Johnson
Johnson & Johnson is a holding corporation that works on the creation, production, and marketing of health-related products. The company is divided into three segments: Medical Devices, Pharmaceuticals, and Consumer. Products used in the over-the-counter pharmaceutical, women’s health, wound care, baby care, oral care, and beauty sectors are included in the consumer section. Therapeutic fields include immunology, infectious illnesses and vaccines, neurology, cancer, cardiovascular and metabolism, and pulmonary hypertension are the emphasis of the pharmaceutical segment. Products for the orthopedic, surgical, cardiovascular, diabetic care, and ocular health disciplines are available from the Medical Devices category. With its headquarters located in New Brunswick, New Jersey, the corporation was formed in 1886 by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr.
Overview of JNJ Stock Price
Revenue for JNJ increased to $85.16 billion in 2023 from $79.99 billion the year before, a 6.46% rise. $35.15 billion in earnings was a 95.94% rise.
| Current Price | $ 160.93 |
| Open | $ 160.16 |
| Previous Close | $ 160.16 |
| 50-Day SMA | $ 152.93 |
| Pe Ratio (TTM) | 24.35 |
| EPS (TTM) | $ 6.73 |
| DIV PS TTM (Yield) | $ 4.47 ($ 2.87) |
| Market Cap | $ 387.40B |
JNJ Stock Price Prediction 2024 To 2030
Johnson & Johnson’s stock price is predicted by our stock price prediction system to reach $301.09 in 2030. Over a six-year period, we project a +69.98% increase in the price of JNJ stock.
| Year | Stock Price Prediction |
| 2024 | $175.31 |
| 2025 | $205.57 |
| 2026 | $221.26 |
| 2027 | $239.71 |
| 2028 | $256.29 |
| 2029 | $274.09 |
| 2030 | $301.09 |
How to Purchase For Johnson & Johnson Stock
In addition to using Zerodha, Upstox, Groww, and Angel One, you can purchase JNJ stock through a number of buying and trading platforms.
Peer Companies For Johnson & Johnson
- Merck & Co Inc
- Pfizer Inc
- Sanofi
- Novartis AG
- Abbvie Inc
Investor Types and Ratios For Johnson & Johnson
Stock in Johnson & Johnson (JNJ) is owned by a combination of retail, institutional, and individual investors. Institutional investors control about 53.90 percent of the company’s shares.
- Insiders – 0.20%
- Mutual Funds – 18.68%
- Public Investors- 35.22%
- Other Institutional Investors – 45.90%
Although these price targets are based on technical analysis, it is important to keep in mind that news and other market factors could potentially affect the performance of the stock. Therefore, these hypothetical objectives should be considered suggestions rather than financial directives. Do your own research before investing in anything.
